{"id":"https://openalex.org/W2943653126","doi":null,"title":"Update on the Management of Myeloproliferative Neoplasms","display_name":"Update on the Management of Myeloproliferative Neoplasms","publication_year":2016,"publication_date":"2016-10-01","ids":{"openalex":"https://openalex.org/W2943653126","mag":"2943653126"},"language":"en","primary_location":{"id":"mag:2943653126","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/nccn/update-management-myeloproliferative-neoplasms","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5880-7972","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5039057642"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.32611091,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":1.0},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":1.0},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":1.0},{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.6039999723434448},{"id":"https://openalex.org/keywords/symptoms","display_name":"clinical symptoms","score":0.75},{"id":"https://openalex.org/keywords/treatment","display_name":"treatment","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.47055554389953613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46978679299354553},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3480026423931122},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21191731095314026}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2943653126","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/nccn/update-management-myeloproliferative-neoplasms","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2926755760","https://openalex.org/W4411786420","https://openalex.org/W2549876439","https://openalex.org/W2988702357","https://openalex.org/W4394698696","https://openalex.org/W4380047523","https://openalex.org/W4404525881","https://openalex.org/W37771174","https://openalex.org/W6922663323","https://openalex.org/W2210373539"],"abstract_inverted_index":{"In":[0],"this":[1],"interview":[2],"we":[3],"discuss":[4],"symptoms":[5],"and":[6,13,16],"prognosis":[7],"for":[8],"patients":[9],"with":[10],"polycythemia":[11],"vera":[12],"essential":[14],"thrombocythemia":[15],"the":[17],"treatment":[18],"of":[19],"myelofibrosis.":[20]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-05-09T00:00:00"}